Home/Filings/4/0001209191-21-068849
4//SEC Filing

Booth Andrew 4

Accession 0001209191-21-068849

CIK 0001703057other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 5:58 PM ET

Size

6.8 KB

Accession

0001209191-21-068849

Insider Transaction Report

Form 4
Period: 2021-12-07
Booth Andrew
Chief Financial Officer
Transactions
  • Award

    Share Option (right to buy)

    2021-12-07+406,0205,884,820 total
    Exercise: $14.55Exp: 2031-12-07Common Shares (406,020 underlying)
Holdings
  • Common Shares

    (indirect: By Spouse)
    130,959
  • Common Shares

    53,500
Footnotes (1)
  • [F1]The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001834411

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:58 PM ET
Size
6.8 KB